Docoh
Loading...

AURA Aura Biosciences

Filed: 12 Nov 21, 4:30pm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. __)*

 

Aura Biosciences, Inc.
 (Name of Issuer)

 

Common Stock, par value $0.00001 per share
 (Title of Class of Securities)

 

05153U107
 (CUSIP Number)

 

November 2, 2021
 (Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  o Rule 13d-1(b)

 

  x Rule 13d-1(c)

 

  o Rule 13d-1(d)

 

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 2

 

1

NAMES OF REPORTING PERSONS

 

Chiesi Ventures, LP

2CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a) o

  (b) o

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
5

SOLE VOTING POWER

 

None

OWNED BY
EACH
REPORTING
6

SHARED VOTING POWER

 

1,625,071 (1)

PERSON WITH7

SOLE DISPOSITIVE POWER

 

None

 8

SHARED DISPOSITIVE POWER

 

1,625,071 (1)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,625,071 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.8% (2)

12

TYPE OF REPORTING PERSON

 

PN

    

(1) These securities are held by Chiesi Ventures, LP (“Chiesi Ventures”). Chiesi Ventures, Inc., the general partner of Chiesi Ventures (“Chiesi”), has the power to vote and dispose of securities directly owned by Chiesi Ventures, and Mr. Giacomo Chiesi, the President of Chiesi, has the power to direct Chiesi as to such voting and disposition. Chiesi and Mr. Chiesi each disclaims beneficial ownership of the securities held by Chiesi Ventures except to the extent of its or his pecuniary interest therein.

(2) This percentage is calculated based on 28,409,613 shares of common stock, par value $0.00001 per share (“Common Stock”), outstanding of Aura Biosciences, Inc. (the “Issuer”), as set forth in the Issuer’s Prospectus filed pursuant to Rule 424(b)(4), filed with the Securities and Exchange Commission (the “Commission”) on November 1, 2021.

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 3

 

1

NAMES OF REPORTING PERSONS

 
Chiesi Ventures, Inc.

2CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a) o

  (b) o

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
5

SOLE VOTING POWER

 

None

OWNED BY
EACH
REPORTING
6

SHARED VOTING POWER

 

1,625,071 (1)

PERSON WITH7

SOLE DISPOSITIVE POWER

 

None

 8

SHARED DISPOSITIVE POWER

 

1,625,071 (1)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,625,071 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.8% (2)

12

TYPE OF REPORTING PERSON

 

CO

    

(1) These securities are held by Chiesi Ventures. Chiesi, the general partner of Chiesi Ventures, has the power to vote and dispose of securities directly owned by Chiesi Ventures, and Mr. Giacomo Chiesi, the President of Chiesi, has the power to direct Chiesi as to such voting and disposition. Chiesi and Mr. Chiesi each disclaims beneficial ownership of the securities held by Chiesi Ventures except to the extent of its or his pecuniary interest therein.

(2) This percentage is calculated based on 28,409,613 shares of Common Stock outstanding of the Issuer, as set forth in the Issuer’s Prospectus filed pursuant to Rule 424(b)(4), filed with the Commission on November 1, 2021.

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 4

 

1

NAMES OF REPORTING PERSONS

 
Giacomo Chiesi

2CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a) o

  (b) o

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Italy

NUMBER OF
SHARES
BENEFICIALLY
5

SOLE VOTING POWER

 

None
OWNED BY
EACH
REPORTING
6

SHARED VOTING POWER

 

1,625,071 (1)

PERSON WITH7

SOLE DISPOSITIVE POWER

 

None

 8

SHARED DISPOSITIVE POWER

 

1,625,071 (1)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,625,071 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.8% (2)

12

TYPE OF REPORTING PERSON

 

IN

    

(1) These securities are held by Chiesi Ventures. Chiesi, the general partner of Chiesi Ventures, has the power to vote and dispose of securities directly owned by Chiesi Ventures, and Mr. Giacomo Chiesi, the President of Chiesi, has the power to direct Chiesi as to such voting and disposition. Chiesi and Mr. Chiesi each disclaims beneficial ownership of the securities held by Chiesi Ventures except to the extent of its or his pecuniary interest therein.

(2) This percentage is calculated based on 28,409,613 shares of Common Stock outstanding of the Issuer, as set forth in the Issuer’s Prospectus filed pursuant to Rule 424(b)(4), filed with the Commission on November 1, 2021.

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 5

 

Item 1.

 

(a)Name of Issuer:

 

Aura Biosciences, Inc.

 

(b)Address of Issuer’s Principal Executive Offices:

 

85 Bolton Street

Cambridge, MA 02140

 

Item 2.

 

(a)Name of Person Filing:

 

Chiesi Ventures, LP

 

Chiesi Ventures, Inc.

 

Mr. Giacomo Chiesi

 

(b)Address or Principal Business Office or, if none, Residence:

 

As to Chiesi Ventures, LP, Chiesi Ventures, Inc., and Giacomo Chiesi: 2520 Meridian Parkway, Suite 400, Durham, North Carolina 27713

 

(c)Citizenship:

 

As to Chiesi Ventures, LP: Delaware limited partnership

 

As to Chiesi Ventures, Inc.: Delaware corporation

 

As to Mr. Giacomo Chiesi: Italian citizen

 

(d)Title of Class of Securities:

 

Common Stock

 

(e)CUSIP Number:

 

05153U107

 

Item 3.If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not Applicable

 

Item 4.Ownership.

  

 (a)

Amount beneficially owned:

 

Chiesi Ventures, LP

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

 

 

1,625,071

1,625,071 (1)

1,625,071 (1)

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 6

 

 (b)

Percent of class:

 

Chiesi Ventures, LP.

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

 

 

5.8%

5.8%

5.8%

  

 (c)Number of shares as to which such person has:

 

 (i)Sole power to vote or to direct the vote of:

 

 (b)

Chiesi Ventures, LP.

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

0

0

0

 

 (ii)Shared power to vote or to direct the vote of:

 

 (b)

Chiesi Ventures, LP.

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

1,625,071

1,625,071 (1)

1,625,071 (1)

 

 (iii)Sole power to dispose or to direct the disposition of:

 

 (b)

Chiesi Ventures, LP.

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

0

0

0

  

 (iv)Shared power to dispose or to direct the disposition of:

 

 (b)

Chiesi Ventures, LP.

Chiesi Ventures, Inc.

Mr. Giacomo Chiesi

1,625,071

1,625,071 (1)

1,625,071 (1)

 

(1)      These securities are held by Chiesi Ventures. Chiesi, the general partner of Chiesi Ventures, has the power to vote and dispose of securities directly owned by Chiesi Ventures, and Mr. Giacomo Chiesi, the President of Chiesi, has the power to direct Chiesi as to such voting and disposition. Chiesi and Mr. Chiesi each disclaims beneficial ownership of the securities held by Chiesi Ventures except to the extent of its or his pecuniary interest therein.

 

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not Applicable.

 

Item 8.Identification and Classification of Members of the Group.

 

Not Applicable.

 

 

 

 

CUSIP No. 05153U107SCHEDULE 13GPage 7

 

Item 9.Notice of Dissolution of Group.

 

Not Applicable.

 

Item 10.Certifications.

 

By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 

 

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. 

 

Dated:  November 12, 2021

 

 Chiesi Ventures, LP
   
 By: Chiesi Ventures, Inc.
   
  By:/s/ Giacomo Chiesi
  Name: Giacomo Chiesi
 Title: President

 

 Chiesi Ventures, Inc.
   
  By:/s/ Giacomo Chiesi
  Name: Giacomo Chiesi
 Title: President

 

 /s/ Giacomo Chiesi
 GIACOMO CHIESI

 

 

 

 

MATERIALS TO BE FILED AS EXHIBITS

 

Exhibit 99.1Joint Filing Agreement